India’s trade remedies agency pushed its revived resorcinol dumping case forward with twin procedural orders on July 25, keeping sole domestic producer Atul Ltd’s second bid in two years for renewed duties on Chinese and Japanese imports firmly on track.
NEW DELHI, July 27, 2026: India’s Directorate General of Trade Remedies moved its freshly revived anti-dumping investigation into resorcinol imports from China and Japan into a higher gear on Friday, publishing two notifications that define the product scope of the case and extend the deadline for foreign producers, exporters and Indian importers to file their questionnaire responses. The twin notices, posted on the DGTR’s website on July 25 under the case concerning imports of resorcinol originating in or exported from China PR and Japan, set out the product under consideration and product control number methodology that will govern how the agency compares prices, and grant interested parties additional time to submit the detailed cost and sales data on which the investigation’s dumping and injury calculations will rest.
The procedural steps are unglamorous, but they matter. They confirm that the investigation the DGTR opened on June 18, 2026 at the request of Atul Ltd, the only company that makes resorcinol in India, is advancing on schedule toward the determinations that could restore a duty wall first erected in 2018 and left to lapse. For a chemical that flows into tires, rubber goods, wood adhesive resins, ultraviolet stabilizers, dyes, pharmaceuticals and flame retardants, the outcome will decide whether Indian buyers keep sourcing freely from the only two countries that currently supply them, or pay duties designed to keep their sole domestic supplier viable.
The case is also a study in persistence. This is the second original anti-dumping investigation into the same product from the same two countries in under two years. An earlier probe, opened on September 30, 2024, ended with final findings dated September 24, 2025 in which the DGTR concluded that dumped Chinese and Japanese resorcinol had materially injured Atul and recommended definitive anti-dumping duties to the finance ministry, which takes the final call on imposition. No customs notification giving effect to that recommendation appears in the public record of anti-dumping impositions reviewed by this publication, and within nine months the agency had opened a fresh case built on newer data. The revival attempt now runs in parallel with a season of unusual openness in Indian trade policy, days after New Delhi completed its eighth Trade Policy Review at the World Trade Organization and weeks after its trade agreement with the United Kingdom entered into force.
Two Notices, One Signal
The July 25 postings are listed on the DGTR’s public docket for the case as a “PUC/PCN Methodology” notification and an “Extension of timeline for filling of Questionnaire Responses,” each running to roughly a hundred kilobytes of procedural text. In trade remedy practice, the product under consideration and product control number framework determines how imported grades are matched against domestic production for fair price comparisons, an issue that can move dumping margins by wide swings, while questionnaire extensions typically respond to requests from exporters and importers who face heavy data demands. Participation runs through the DGTR’s SETU electronic filing portal, where the case was registered under SETU Case ID AD/OI/022/2026, according to the initiation notification summarized by trade publication World Trade Scanner.
The parameters of the new investigation are broader and more current than its predecessor’s. According to World Trade Scanner’s account of the June 18 initiation notification, the period of investigation covers January 1 to December 31, 2025, with injury examined over 2022-23, 2023-24, 2024-25 and the investigation period. The product, also known as 1,3-benzenediol with CAS number 108-46-3, is classified under Indian tariff item 2907 21 00. Because India treats China as a non-market economy for anti-dumping purposes, the notification indicates that normal value for Chinese producers has been constructed from Indian production costs plus reasonable profit, and the same constructed approach was applied to Japan for want of reliable domestic price data, the publication reported.
The commerce ministry’s reasoning at initiation was straightforward. “On the basis of the duly substantiated application filed by the applicant and having satisfied itself, on the basis of the prima facie evidence submitted by the applicant, regarding dumping of the subject goods…the authority hereby initiates an anti-dumping investigation,” the DGTR’s notification said, as quoted in a Press Trust of India dispatch carried by Business Standard on June 19. The PTI report noted that the directorate will determine the existence, degree and effect of the alleged dumping, and that the finance ministry decides whether to impose any duty the DGTR recommends.
A Duty That Keeps Coming Back
Resorcinol protection in India has a long and interrupted history. An anti-dumping duty on the chemical from China and Japan was imposed through Notification No. 13/2018-Customs (ADD) dated March 21, 2018, according to World Trade Scanner, which reported that the measure lapsed three years before the current case began. Atul, part of the Lalbhai group and one of India’s oldest chemical companies, has been trying to rebuild that wall ever since the duty expired.
Its first attempt came quickly. On September 30, 2024, the DGTR initiated an original anti-dumping investigation, Case No. AD(OI)-25/2024 under file number 6/27/2024-DGTR, on Atul’s application. The Global Trade Alert database, which logs the initiation as intervention 140495 and classifies it as likely harmful to foreign commercial interests, records that the products fell under HS subheading 2907.21.00 and that the case followed an application lodged by Atul Limited on behalf of the Indian industry. The registered interested parties list published by the DGTR in November 2024 shows the breadth of the fight that followed: Sumitomo Chemical of Japan and Zhejiang Hongsheng Chemical of China as cooperating producers, trading houses Sojitz Corporation, East West Corporation, Amino-Chem of Hong Kong, Changshan Haicheng Chemical and Zhejiang Dystar Trading as exporters, Indian importers and users including Techno Waxchem, Black Rose Industries and Somu Organo-Chem, the Embassy of Japan as a government participant, and Korea’s Songwon Industrial Group registered, unusually, as a supporter of the complaint.
That investigation ended in Atul’s favor on paper. In non-confidential final findings dated September 24, 2025, the DGTR determined that dumping margins for the period examined fell in the range of 25 to 35 percent for Zhejiang Hongsheng and 35 to 45 percent for other Chinese producers, and 30 to 40 percent for Sumitomo Chemical with 50 to 60 percent for other Japanese suppliers, with injury margins of 15 to 25 percent for the two cooperating producers and 30 to 45 percent for non-cooperators, according to the findings document. The authority recommended definitive anti-dumping duties, with producer-specific amounts set out in the duty table of the notification. A tabulation of the September 2025 findings published by World Trade Scanner lists a recommended amount of 6,244 US dollars per tonne against both China and Japan; the precise form and company-wise application of the recommended measure are specified in the official duty table, and the recommended rates in the new investigation, if any emerge, will be detailed only in its own final findings notification.
What happened next is conspicuous by its absence. Under India’s anti-dumping rules the finance ministry ordinarily has three months to act on a DGTR recommendation, and no imposition notification for resorcinol surfaces in publicly available customs records from late 2025 or early 2026. India’s finance ministry has in recent years declined to operationalize a meaningful share of the DGTR’s recommendations, a pattern trade lawyers track closely, and a Lexology review of the July-September 2025 quarter noted that the DGTR had recommended trade remedy measures on 23 products whose implementation was awaited. Against that backdrop, the June 2026 re-initiation with a 2025 calendar-year data set reads as a deliberate reset: a fresh evidentiary record, current prices, and a second run at a recommendation the government can act on.
What the Authority Found Last Time
The September 2025 findings, though never converted into duties, map the economics that the new case will revisit. The authority recorded that imports from China and Japan constituted the entirety of India’s resorcinol imports during the period it examined, meaning no third-country supply could explain the domestic industry’s deterioration. It found that Atul had been selling below cost to hold on to customers. “Since the subject goods are a commodity product, the domestic industry has been forced to reduce prices below its cost of sales to retain its market share,” the DGTR wrote in the final findings document.
The document also captures a structural tension that will shape the sequel: India needs more resorcinol than Atul can make. The authority acknowledged that demand in India exceeds domestic capacity, and interested parties argued that only three producers serve the global market. The DGTR was unmoved by the argument that scarcity justifies cheap imports. “Even though there is a demand-supply gap, dumping is an unfair trade practice due to which the sole producer in India is suffering material injury,” the authority stated in the findings. Global supply had already tightened after the shutdown of the resorcinol plant of INDSPEC, the American producer whose exit was cited in submissions recorded by the DGTR as having created a demand-supply gap and abnormal price spikes in the early 2020s, leaving buyers worldwide dependent on a Japanese incumbent, Chinese capacity, and Atul.
Sides Dig In
The battle lines from the first case are likely to reappear almost unchanged. Sumitomo Chemical, Japan’s sole producer, argued through counsel that its home-market position distorted comparisons; the DGTR replied in its findings that the “mere fact that a producer is a sole producer in the country cannot be considered as resulting in prices being overstated, as the product can always be imported into the country, in competition to the domestic goods.” Chinese and Japanese exporters attributed Atul’s troubles to its production technology, to declining demand and to the aftershocks of the Russia-Ukraine conflict on benzene costs, arguments the authority examined and rejected one by one in the non-confidential findings.
Indian importers and users pressed the affordability case hard, and their submissions preview the fight over the new investigation’s outcome. According to the record of post-disclosure comments in the DGTR’s findings, users warned that a “levy of 20% anti-dumping duty will increase the cost of downstream product by 13-18%,” and that duties would penalize consuming industries in a tightly supplied market. The importers also lobbied on the shape of any measure, requesting that ad valorem duties be levied because fixed or reference-price duties would prove punitive when prices fluctuate, per the findings document. Atul, advised by TPM Consultants, countered that the previous reference-price duty had failed precisely because the benchmark sat below prevailing import prices, and pressed for a measure with real bite, according to submissions summarized in the findings.
None of the principal companies has publicly commented on the July 25 procedural notices. Atul has not issued a statement on the new investigation beyond its regulatory filings, and Sumitomo Chemical’s positions are known only through the earlier proceeding. The Embassy of Japan, which registered in the 2024 case, can be expected to follow the revived one; Japanese government participation in Indian chemical anti-dumping proceedings has become routine as Tokyo monitors a growing docket of cases touching its exporters.
The Price of Protection
The economic stakes divide cleanly along the value chain. For Atul, the calculus is existential in this product line: the DGTR’s earlier findings describe a producer whose inventories swelled even as it sold below cost, whose capacity utilization sagged despite demand outstripping national supply, and whose export sales stayed profitable while domestic sales bled, a pattern the authority read as the signature of dumping-induced injury rather than commercial failure. Restored duties would let the company reprice toward its cost of production and, on its own account in the findings, support further capacity investment that current market conditions discourage.
For consuming industries, the arithmetic runs the other way. Resorcinol-formaldehyde resins are a critical adhesion system bonding rubber to tire cord, and tire makers, rubber goods producers and plywood adhesive formulators absorb the chemical’s price directly into their cost base. The users’ own figure in the DGTR record, that a 20 percent duty would inflate downstream product costs by 13 to 18 percent, is contested but establishes the order of magnitude the industry fears. With imports from the two subject countries making up the entirety of foreign supply in the earlier period examined and domestic capacity short of demand, some volume of dutied imports would remain unavoidable, meaning a duty acts partly as a tax on a structural import dependency rather than a switch that redirects purchasing to local supply. That is exactly the trade-off the DGTR weighed and accepted in 2025, and nothing in the market structure has visibly changed since.
The bizarre-seeming sequence, a completed investigation followed immediately by a rerun, also carries a cost of its own. Exporters and importers must fund a second round of lawyers, questionnaires and verification visits within two years for the same product. Trade counsel in New Delhi note that repeat filings after unimplemented recommendations are becoming a feature of the Indian system, as domestic industries treat a lapsed recommendation not as a defeat but as an invitation to return with fresher data.
Global Ripples
For global chemical traders, the case is a reminder that India’s import regime for intermediates can shift abruptly product by product even as its headline trade policy liberalizes. China’s dominance of world chemical intermediate capacity keeps it the default target of Indian trade remedy action, and resorcinol sits alongside a crowded 2025-26 docket of Chinese-origin chemistry cases spanning refrigerants, rubber chemicals and polymer inputs. Japan’s inclusion is rarer and more delicate: Sumitomo is a strategic supplier to Indian tire manufacturing, and Tokyo and New Delhi are otherwise deepening supply chain cooperation. Korean producer Songwon’s support for Atul’s complaint hints at the competitive geometry, with third-country suppliers standing to gain from any duty that reprices Chinese and Japanese material in the Indian market.
Importers with long supply contracts face familiar hedging questions. A new original investigation can produce provisional duties once the DGTR reaches preliminary findings, and definitive measures, if recommended and this time implemented, would likely apply for five years. Buyers who lived through the 2018-2023 duty period have seen the movie before; the difference now is that the interim years demonstrated both the scale of dumping margins the DGTR is prepared to find, up to 60 percent for non-cooperating Japanese suppliers in the September 2025 findings, and the possibility that the finance ministry declines to act at all. That uncertainty cuts both ways, deterring importers from assuming duty-free continuity and exporters from assuming protection is inevitable.
Liberalizing and Fortifying
The resorcinol file advances amid the most active stretch of Indian trade policymaking in a generation, and it captures the deliberate two-handedness of the strategy. On one hand, market opening: India signed its free trade agreement with the European Union on January 27, 2026, the largest such deal either side has concluded, which the European Commission said will eliminate duties on nearly 99.5 percent of Indian exports to the bloc, and the India-UK Comprehensive Economic and Trade Agreement entered into force on July 15, 2026, making 99 percent of Indian goods entering Britain and 90 percent of British goods entering India duty-free or tariff-reduced, according to India’s Press Information Bureau, with the two governments aiming to double bilateral trade from a base of roughly 56 billion dollars. On the other hand, fortification: the DGTR recommended a 12 percent provisional safeguard duty on flat steel products in March 2025, which the government imposed for 200 days and later extended on the agency’s final recommendation of a staggered three-year measure, according to Business Standard and Deccan Herald reporting, and the agency’s anti-dumping initiation tempo across chemicals, steel and electronics inputs has remained brisk through 2026.
That duality was on display in Geneva last week. India completed its eighth WTO Trade Policy Review on July 21 and 23, 2026, with 68 members intervening, according to the Press Information Bureau. Commerce Secretary Rajesh Agarwal told the review that India’s combined goods and services exports reached a record 863.1 billion dollars in 2025-26, up from 676.5 billion dollars in 2021-22, while members pressed India on tariff levels and the transparency of its expanding trade remedy apparatus alongside praise for customs modernization and digital infrastructure, per official accounts of the sessions. For trading partners, the resorcinol case is a data point in the pattern the review probed: a country cutting tariffs preferentially for treaty partners while sharpening the contingent protection tools it applies to everyone else, China above all.
What Comes Next
The immediate calendar belongs to the questionnaire respondents. Under the extended timeline notified on July 25, producers in China and Japan, their exporters, and Indian importers and users must file responses through the SETU portal, after which the DGTR will move through registered-party consolidation, an oral hearing, verification, a disclosure statement and final findings. Indian anti-dumping rules give the authority a year from initiation, extendable, to complete the investigation, placing final findings in mid-2027 on the standard clock, with the possibility of provisional duties before then if the agency follows the pattern of its recent chemical cases. Whatever the DGTR recommends will then land on the finance ministry’s desk, the same desk where the September 2025 recommendation apparently expired.
That, more than any margin calculation, is the variable to watch. The DGTR has already shown it is willing to find substantial dumping and injury on this product; Atul has shown it will keep filing until protection sticks; importers have shown they will contest every duty format on offer. The open question is whether the revenue department, balancing tire industry costs against a lone domestic producer’s survival in a market where demand outruns national capacity, will convert the next recommendation into collected duties. Until it answers, resorcinol will remain what it has been since 2023: a chemical whose Indian price is set in Tokyo and Zhejiang, with New Delhi’s remedy machinery grinding steadily in the background toward another verdict.